Treatment Of Multiple Sclerosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
VCNX | F | Vaccinex, Inc. | -8.00 | |
CGEN | D | Compugen Ltd. | 4.32 | |
ALKS | B | Alkermes plc | 0.59 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Multiple Sclerosis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | F | AdvisorShares Psychedelics ETF | 4.98 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.14 | |
FBT | A | First Trust Amex Biotech Index Fund | 3.68 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 3.06 | |
PSCH | D | PowerShares S&P SmallCap Health Care Portfolio | 2.93 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Oct 2 | ALKS | Alkermes (NASDAQ:ALKS) shareholder returns have been favorable, earning 62% in 5 years |
Related Industries:
Biotechnology
- Treatment Of Multiple Sclerosis
Treatment of multiple sclerosis (MS) is aimed at reducing the frequency and severity of attacks, slowing the progression of the disease, and managing symptoms. Treatment options may include medications, physical therapy, occupational therapy, lifestyle changes, and assistive devices.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles